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Burkholderia cepacia complex bacteria are opportunistic pathogens that cause respiratory tract 36 
infections in susceptible patients, mainly in people with cystic fibrosis (CF). There is convincing 
evidence that B. cepacia complex bacteria can form biofilms, not only on abiotic surfaces (e.g. glass 38 
and plastics), but also on biotic surfaces like epithelial cells, leading to the suggestion that biofilm 
formation plays a key role in the persistent infection of CF lungs. In this review I present an 40 
overview of (i) the molecular mechanisms involved in B. cepacia complex biofilm formation, (ii) 
the increased resistance of sessile B. cepacia complex cells and (iii) the role of quorum sensing in 42 
B. cepacia complex biofilm formation. 
 44 
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Executive summary 46 
Molecular basis of B. cepacia complex biofilm formation 
 QS systems are required for formation of mature biofilms 48 
 Adhesive structures (pili, flagella) are involved in initial stages of biofilm formation 
 Five different exopolysaccharides (including cepacian) are produced by B. cepacia complex 50 
species ; these are likely involved in persistence and invasiveness 
 Cepacian enhances the formation of thick, mature biofilms  52 
Antimicrobial resistance in B. cepacia complex biofilms 
 B. cepacia complex bacteria are higly resistant against a wide range of antimicrobial agents 54 
 Single antibiotics or (double/triple) antibiotic combinations with good in vitro activity often 
fail to clear bacteria from the lung 56 
 Comparing antimicrobial susceptibility between planktonic and sessile cells requires similar 
experimental conditions 58 
 For most antibiotics, the concentrations required to inhibit growth of exponential-phase 
planktonic cultures and freshly-adhered biofilms is similar ; likewise, the concentrations 60 
required to kill planktonic cells in stationary-phase cultures and sessile cells in mature 
biofilms are also similar. 62 
 Sessile B. cepacia complex cells tend to be less susceptible to tobramycin than their 
planktonic counterparts 64 
 Marked differences in susceptibility to disinfectants can be observed between planktonic and 
sessile B. cepacia complex cells, with the latter being considerably more resistant 66 
 In contrast to Pseudomonas aeruginosa, agents interfering with iron-dependent cellular 
processes (e.g. gallium) have little effect on B. cepacia complex biofilms 68 
Role of QS in B. cepacia complex biofilms 
 N-acyl homoserine lactones are used for cell-cell communication in B. cepacia complex 70 
bacteria 
 In some B. cepacia complex species the use of 4-hydroxy-2-alkylquinolines and/or cis-2-72 
dodecenoic acid signalling molecules has been described 
 AHL-based QS plays an important role in biofilm formation in all B. cepacia complex 74 
species, but most likely not in all conditions 
 Inhibitors of the QS system also affect biofilm formation in B. cepacia complex bacteria 76 
Mixed species biofilms 
 B. cepacia complex bacteria can form mixed species biofilms with P. aeruginosa 78 
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The Burkholderia cepacia complex is a group of closely-related Gram-negative bacteria, belonging 80 
to the -Proteobacteria. At present, the B. cepacia complex contains 17 species : Burkholderia 
cepacia, Burkholderia multivorans, Burkholderia cenocepacia, Burkholderia stabilis, Burkholderia 82 
vietnamiensis, Burkholderia dolosa, Burkholderia ambifaria, Burkholderia anthina, Burkholderia 
pyrrocinia, Burkholderia ubonensis, Burkholderia latens, Burkholderia diffusa, Burkholderia 84 
arboris, Burkholderia seminalis, Burkholderia metallica, Burkholderia contaminans and 
Burkholderia lata [1-4]. B. cepacia complex species are notorious for causing respiratory tract 86 
infections in susceptible individuals, most notably people with cystic fibrosis (CF) or chronic 
granulomatous disease (CGD) [5,6]. The problematic treatment of B. cepacia complex infected 88 
patients and the capacity of these bacteria to cause severe inflammation, progressive decline of the 
lung function and invasive infections, have led to intensive research on a broad variety of potential 90 
virulence factors. These virulence traits include the resistance against antimicrobial agents, the 
formation of biofilms and the synthesis of exopolysaccharides (EPS), the adherence to mucin and 92 
epithelial cells, the ability to invade epithelial cells and macrophages, the production of catalases, 
superoxide dismutases and other reactive oxygen species (ROS)- degrading/scavenging proteins, 94 
the secretion of lipases, proteases, haemolysins and siderophores and the use of quorum sensing 
(QS) signals that modulate the expression of genes involved in virulence [7]. Over the past decade, 96 
biofilm formation by various B. cepacia complex bacteria has been described (see for example 
references [8-14]). Interestingly, B. cepacia complex bacteria were not only found to be capable of 98 
colonizing various abiotic surfaces (e.g. glass and plastics), but were also found to form biofilms on 
biotic surfaces like epithelial cells [9]. This has led to the suggestion that biofilm formation plays a 100 
key role in the persistent infection of CF lungs [15,16].  
 102 
 
Molecular basis of B. cepacia complex biofilm formation 104 
Several studies have focussed on the factors required for initial surface adhesion and subsequent 
biofilm formation and maturation [17-20]. Adhesion to surfaces is often mediated through 106 
specialized surface structures like fimbriae or pili and in many organisms also requires flagellar 
motility [21]. B. cepacia complex bacteria are equipped with mesh, filamentous, spine, spike and/or 108 
cable pili [22]. Although cable pili are well known for their role in adhesion to epithelial cells, 
genes encoding these pili are not widely distributed in the B. cepacia complex and not all cblA-110 
positive strains produce the pili [23]. Hence, their exact role (and the role of other pili) in B. cepacia 
complex biofilm formation is at present unclear [16]. A screening of 5000 random insertion mutants 112 
of B. cenocepacia H111 to determine their ability to form biofilms, led to the identification of 13 
mutants defective in the formation of a mature biofilm [18]. The genes involved either encoded 114 
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surface proteins or regulatory factors or they were required for the biogenesis and maintenance of 
the outer membrane. In addition, some of the identified mutants were defective in QS, confirming 116 
previous research on the necessity of the CepIR QS system for the formation of mature biofilms in 
B. cenocepacia H111 [17] (see below for more details). Confocal laser scanning microscopy images 118 
revealed markedly different ultrastructures for the mutant biofilms compared to the wild type 
biofilms [18]. The same study demonstrated that swarming motility is not required for the formation 120 
of mature B. cenocepacia biofilms; yet, mutant strains lacking functional flagella were severely 
impaired in their initial adhesion.  These results were confirmed by Saldias et al. [19], who 122 
demonstrated that RpoN (a sigma factor that regulates flagellar motility) is required for biofilm 
formation. A putative sensor kinase response regulator AtsR has also been identified as an 124 
important regulator of biofilm formation in B. cenocepacia, however none of the genes regulated by 
AtsR have been identified thus far [20]. 126 
Alginate, a high molecular weight acetylated polymer composed of nonrepetitive monomers of β-
1,4 linked L-guluronic and D-mannuronic acids,  is an important component of the Pseudomonas 128 
aeruginosa biofilm matrix, but other EPS (including Pel and Psl) are also involved [24]. The ability 
of B. cepacia complex bacteria to produce EPS has been studied extensively and five different EPS, 130 
including PS-I, PS-II (cepacian) and levan, have been identified [25]. Cepacian, a 
heteropolysaccharide with a heptasaccharide basic unit, is the most frequently identified EPS in B. 132 
cepacia complex bacteria and it has been isolated from mucoid as well as from non-mucoid strains 
[25-30]. Although not systematically studied so far, it appears that some B. cepacia complex strains 134 
exclusively produce cepacian, while others also co-produce small(er) amounts of other extracellular 
polysaccharides [8,29]. 136 
The genes in the bceABCDEFGHIJKL gene cluster encode the enzymes required for the formation 
of the sugar precursors, the glycosyltransferases and the proteins involved in polymerization and 138 
export of cepacian [31]. Interestingly, the B. cenocepacia type strain, B. cenocepacia J2315, does 
not produce cepacian, as a frameshift mutation is present in bceB (BCAM0856, coding for a 140 
putative glycosyltransferase) [31-33]. Cepacian is often acetylated [29,31,34,35], and although the 
role of cepacian acetylation remains unknown, it may protect the bacteria from opsonisation and 142 
phagocytosis, as is the case with alginate in P. aeruginosa [35,36].  
B. cepacia complex EPS also scavenges ROS and it interferes with neutrophil chemotaxis [37]; the 144 
latter characteristics might explain why production of EPS enhances persistence in a mouse model 
system [10,38]. In P. aeruginosa infected CF patients, mucoid alginate-producing isolates are 146 
associated with a progressive deterioration of the lung function and with an increased resistance 
against antimicrobial agents and the immune system. In addition, excessive alginate production is 148 
found to be important for the formation of thick P. aeruginosa biofilms in the CF lung [39]. Cunha 
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et al. [10] reported that cepacian is not required for biofilm formation, although it may enhance the 150 
formation of thick, mature biofilms. Contrary to the non-mucoid to mucoid phenotype switch in P. 
aeruginosa, the transition from a mucoid tot non-mucoid phenotype has been observed in B. 152 
cepacia complex isolates from chronically infected CF patients [40]. This observation suggests that 
EPS production is involved in the persistence of the infections, whereas the loss of EPS production 154 
might increase the invasiveness of these strains [39].  
Further research is required to elucidate the role of biofilm formation and/or EPS production in the 156 
persistence and virulence of B. cepacia complex bacteria [16]. 
 158 
  
Antimicrobial resistance in B. cepacia complex biofilms 160 
Mechanisms of resistance in planktonic B. cepacia complex cells 
B. cepacia complex bacteria are highly resistant against multiple antibiotics, disinfectants as well as 162 
preservatives [41]. This panresistance is caused by various mechanisms, including limited 
permeability of the outer membrane, changes in lipopolysaccharide (LPS) structure and the 164 
presence of several multidrug efflux pumps, inducible chromosomal -lactamases and altered 
penicillin-binding proteins [7,41]. B. cepacia complex bacteria are intrinsically resistant to cationic 166 
antimicrobial agents due the unique structure of their LPS. In addition, porins can severely limit the 
permeability of the outer membrane [41] and this decreased porin permeability has been associated 168 
with resistance against chloramphenicol, trimethoprim, ciprofloxacin and -lactam antibiotics 
[42,43]. Multiple Resistance-Nodulation-Division (RND) efflux pumps have been identified in the 170 
genome of B. cenocepacia J2315 [44]. One of these efflux pumps is highly upregulated in the 
presence of chloramphenicol, whereas another efflux pump appears to be involved in the resistance 172 
to fluoroquinolones and streptomycin [44,45]. Furthermore, Nair et al. [46] reported that efflux of 
chloramphenicol, trimethoprim and ciprofloxacin is mediated by a P. aeruginosa MexAB-OprM 174 
homolog in B. cenocepacia. The role of all other putative RND efflux pumps for which genes were 
identified in the B. cenocepacia J2315 genome is at present unclear [44]. Inducible -lactamases 176 
impair the antibiotic activity of -lactamase sensitive penicillins and various genes encoding these 
inducible -lactamases (two class A, one class C and one class D -lactamase) are present within 178 
the B. cenocepacia J2315 genome [32]. Thus far no aminoglycoside inactivating enzymes have 
been confirmed experimentally but genes encoding a putative aminoglycoside O-180 
phosphotransferase and a putative aminoglycoside O-adenyltransferase have been identified in the 
B. cenocepacia J2315 genome sequence [32,41]. In addition, although co-trimoxazole is still used 182 
in patients chronically infected with B. cepacia complex bacteria, resistance to trimethoprim (due to 
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the production of a altered trimethoprim dihydrofolate reductase) has frequently been reported [47-184 
49].  
 186 
Resistance mechanisms in biofilms 
Several mechanisms are thought to be involved in biofilm antimicrobial resistance, including  slow 188 
penetration of the antimicrobial agent in the biofilm, biofilm heterogeneity (including the presence 
of zones of slow or no growth), presence of a small population of extremely resistant “persister” 190 
cells and biofilm-specific adaptive stress response [50-52]. Apart from this last mechanism (see 
next sections) most of these mechanisms have not been investigated in B. cepacia complex 192 
biofilms.  
The rate of transport of antimicrobial agents  into biofilms is important, unlike for planktonic cells 194 
where mixing a suspension of the latter with an antimicrobial agent rapidly exposes all cells to the 
full dose. However, if the rate of antibiotic penetration
 
through a biofilm is decreased relative to the 196 
rate of transport
 
through a liquid then the bacteria
 
may be exposed to a gradually increasing dose of 
the antibiotic
 
and may have time to mount a defensive response to the agent [53]. Penetration of 198 
antimicrobial agents into microbial biofilms has been the subject of debate for almost 30 years 
[54,55], resulting in literature reports in favour as well as against the presence of a diffusion barrier 200 
in biofilms (reviewed in [55]). While physicochemical calculations indicate that for most 
compounds these limitations are not expected to contribute to a substantial decrease in penetration 202 
[55,56], experimental data suggest that this retardation is often compound- and/or biofilm-specific. 
This is clearly illustrated by the penetration of antimicrobial agents into the alginate-containing P. 204 
aeruginosa biofilm. The penetration of aminoglycoside antibiotics such as gentamicin and 
tobramycin is considerably slower than that of -lactam antibiotics, which can be explained by the 206 
observation that, unlike -lactams, aminoglycosides bind very well to alginate [57-59]. In addition, 
the presence of inactivating compounds can greatly influence the effective penetration : e.g. 208 
extracellular -lactamase activity can have a dramatic effect on the penetration of penicillins in 
P.aeruginosa biofilms [60,61].  210 
Gradients of nutrients, oxygen, signalling molecules and metabolic end products occur in biofilms 
due to differences in metabolic activities and/or differences in transport of molecules. As a result of 212 
these gradients, considerable structural, chemical and biological heterogeneity can be found within 
a biofilm [62]. Cells at the surface of a biofilm usually do not experience shortage of oxygen and/or 214 
nutrients, but in deeper areas of the biofilm depletion of these essential compounds may lead to the 
presence of metabolically inactive cells that are less suceptible to the action of antimicrobial 216 
compounds and are difficult to eradicate [62].  
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The presence of “persister cells” is also a possible mechanism responsible for the increased resistance 218 
in sessile microbial populations. These persisters can tolerate the presence of certain antimicrobial 
agents (i.e. they are not killed) and can be considered as specialised survivor cells [63-65]. Persisters 220 
are not mutants, but phenotypic variants of the wild type (WT) which, after removal of the selective 
pressure (i.e. the antimicrobial treatment) give rise to a WT culture which again contains only a small 222 
fraction of persisters [66]. Persister cells have already been observed in several microorganisms, 
including the bacteria P. aeruginosa, Staphylococcus aureus and Escherichia coli and the dimorphic 224 
fungus Candida albicans [63,66-70]. While the phenomenon of persisters is not limited to biofilm 
populations, it has been observed that the fraction of persisters is often higher in sessile populations 226 
than in planktonic populations, although there can be marked species- and antibiotic-dependent 
differences [69,71,72]. Recently it was shown that in planktonic P. aeruginosa cultures, the fraction 228 
of persisters increases in response to the quorum sensing molecule 3-oxo-C12 homoserine lactone and 
the secreted phenazine pyocyanin, linking antimicrobial resistance due to persister formation with QS 230 
[73].  
Biofilm-specific adaptive stress responses will be discussed in the next sections. 232 
 
Effect of antibiotics and disinfectants on B. cepacia complex biofilms 234 
Caraher et al. [74] showed that for B. multivorans, B. cenocepacia and B. dolosa strains (2 strains 
each), the minimal concentrations required to inhibit biofilms (minimal biofilm inhibitory 236 
concentration, MBIC) were considerably higher than the minimum inhibitory concentrations (MIC) 
for planktonic cells, when the -lactams meropenem and piperacillin-tazobactam were tested. 238 
However, ceftazidime (also a -lactam), ciprofloxacin, azithromycine, and the aminoglycosides 
tobramycine and amikacin, were effective at inhibiting B. cepacia complex biofilms, although high 240 
concentrations were often required. In a larger study, Peeters et al. [75] investigated the in vitro 
activity of six antibiotics (ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycine and 242 
trimethoprim/sulfametoxazole) against 38 B. cepacia complex isolates (2-4 strains per species). The 
growth inhibitory concentrations for exponentially growing planktonic cells and freshly adhered (4 244 
h) sessile cells were similar. This somewhat surprising finding was in contrast with results from 
other studies, and this is likely due to differences in methodology. In order to allow a correct 246 
comparison between MIC and BIC, experimental conditions should be identical ;  this is illustrated 
by the observation that resistance to ciprofloxacine and ceftazidime changes dramatically during 248 
exponential growth of both planktonic and sessile cultures [76]. When bactericidal activity against 
stationary phase planktonic cultures and mature (24 h old) biofilms was evaluated, major 250 
differences were also not observed, although a marked decrease in the susceptibility of sessile cells 
towards tobramycine was observed [68]. Combining multiple antibiotics to increase the in vitro 252 
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effect against biofilm-grown B. cepacia complex isolates is not straightforward. Dales et al. [77] 
showed that 59% of 47 B. cepacia complex isolates recovered from CF patients (the majority 254 
belonging to B. cenocepacia) were resistant to all 27 double antibiotic combinations tested, while 
18% of all isolates were resistant to all 67 triple antibiotic combinations. The most effective double 256 
antibiotic combination was meropenem combined with high-dose (200 µg/ml) tobramycin (35% of 
all isolates were inhibited), while the most effective triple antibiotic combination contained 258 
meropenem, piperacillin-tazobactam and high-dose tobramycin (53% of all isolates were inhibited).  
With regard to resistance to disinfectants, marked differences in susceptibilities between planktonic 260 
and sessile B. cenocepacia cultures were observed [78]. While treatments with acetic acid (1.25%, 
15-60 min), dettol (5%, 5-30 min), ethanol (70%, 2-10 min), hot water (70°C, 15-60 min), hydrogen 262 
peroxide (0.5-3%, 30 min), cetrimide (0.15%, 15 min) and NaOCl (0.05% - 0.3%, 5 min) resulted in 
reductions of at least 99.999% in planktonic cultures, sessile populations were more resistant. 264 
Especially treatments with acetic acid, chlorhexidine, hydrogen peroxide and NaOCl did not result 
in the eradication of all sessile B. cenocepacia cells. The reduced susceptibility to oxidising 266 
disinfectants not only has implications for infection control practices but, as these oxidative agents 
are being produced by neutrophils as part of the endogenous defence against microorganisms [79], 268 
may also have implications for pathogenesis. Reduced activity of a cetylpyridinium chloride (CPC) 
nanoemulsion against sessile B. cepacia complex strains has also been reported and the median 270 
increase in MBIC and MBEC compared to the respective MICs and MBCs for the six B. cepacia 
complex strains tested was 12-fold and 11-fold, respectively [80].  272 
 
Effect of agents that interfere with iron-dependent cellular processes 274 
In 2005, Banin et al. showed that iron is essential for the development of mature, structured, P. 
aeruginosa biofilms, as mutations in the high-affinity pyoverdine iron acquisition system result in 276 
thin, unstructured, biofilms [81]. Subsequently, it was shown that physiological concentrations of 
the iron-binding glycoprotein lactoferrin inhibited the growth of planktonic and sessile B. cepacia 278 
complex cells, and that B. cepacia complex biofilms formed in the presence of lactoferrin contained 
significantly less biomass than untreated biofilms after 24 h. However, several B. cepacia complex 280 
strains were capable of overcoming this antibiofilm effect and at 48 h treated biofilms were very 
similar to untreated ones. Addition of lactoferrin also decreased the MBIC for rifampicin (2-4 fold) 282 
[82]. 
Kaneko et al. [83] very convincingly showed that gallium (a transition metal capable of disrupting 284 
iron-dependent cellular processes) inhibits P. aeruginosa biofilm formation and kills sessile cells in 
vitro. In addition, gallium was shown to be effective in several in vivo P. aeruginosa infection 286 
models. However, using a similar approach it was recently shown that the effect of gallium against 
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B. cepacia complex biofilms is rather limited [84]. In the presence of physiological iron 288 
concentrations, biofilms formed by the B. cenocepacia strains investigated appeared to be 
insensitive to gallium (concentrations up to 64 mg/l), while only a moderate effect was observed for 290 
B. multivorans and B. dolosa. These experiments were carried out with gallium nitrate ; subsequent 
experiments with gallium maltolate revealed that the latter was even less effective (own 292 
unpublished data).  
 294 
Molecular response of sessile B. cenocepacia cells to antibiotics and disinfectants 
As described above, sessile B. cenocepacia cells are relatively insenstive to oxidising disinfectants 296 
like H2O2 and NaOCl [78]. When the transcriptional response of treated and untreated B. 
cenocepacia biofilms was compared, it was observed that exposure to these agents resulted in an 298 
upregulation of 315 (4.4%) and 386 (5.4%) genes, respectively,  while transcription of 185 (2.6%) 
and 331 (4.6%) genes was decreased in response to H2O2 or NaOCl treatments, respectively [85]. 300 
Not surprisingly, many of the upregulated genes in the treated biofilms are involved in (oxidative) 
stress responses, emphasizing the importance of the efficient neutralization and scavenging of ROS. 302 
In addition, multiple upregulated genes encode proteins that are necessary to repair ROS-induced 
cellular damage. In agreement with what was observed for P. aeruginosa [86], ahpC and ahpF were 304 
highly upregulated, while katB was only modestly upregulated [85]. Treatments with H2O2 or 
NaOCl also resulted in the increased transcription of several organic hydroperoxide resistance (ohr) 306 
genes, including BCAS0085.  
To my knowledge the molecular response of sessile B. cepacia complex cells to antibiotics has not 308 
been investigated. However, the changes in gene expression of planktonic B. cenocepacia J2315 
cells in response to sub-inhibitory concentrations of meropenem, trimethoprim/sulfamethoxazole 310 
and amikacin were studied [87]. Only a small number of genes appeared up- or downregulated, and 
the upregulated genes included genes encoding -lactamases (meropenem), acetyltransferase 312 
(amikacin) and aidA (trimethoprim). The latter gene encodes a nematocidal protein [88] that is 
positively regulated by the QS regulator CepR and negatively by another QS regulator, CciR 314 
[89,90] (see below for details). Many of the genes upregulated in the presence of antibiotics were 
also upregulated in planktonic stationary phase cultures, suggesting that they may also be relevant 316 
in the biofilm mode of life [87].  
 318 
 
Role of QS in B. cepacia complex biofilms 320 
N-acyl homoserine lactone based QS 
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QS systems control the expression of various virulence factors and these systems are considered to 322 
be important regulators of pathogenicity [91]. In B. cepacia complex bacteria (like in many other 
Gram-negative bacteria), the cell-density dependent coordination of gene expression involves the 324 
use of N-acyl homoserine lactone (AHL) signalling molecules [16]. The AHL-based QS system was 
first discovered and studied in detail in the bioluminescent Vibrio species Vibrio harveyi and Vibrio 326 
fischeri [92,93]. AHLs are produced intracellularly by an AHL synthase (LuxI homologue) and will 
accumulate extracellularly. Once a certain threshold concentration is reached, AHLs will bind to a 328 
response regulator (LuxR homologue) and the resulting complex will bind to a promotor, activating 
the transcription of QS regulated genes. Synthesis of AHLs was found to be widespread among B. 330 
cepacia complex species, although strain- and species-dependent differences were observed 
[8,94,95]. The CepIR QS system is found in all B. cepacia complex species [16]. In this system, the 332 
AHL synthase CepI predominantly synthesizes N-octanoyl-homoserine lactone (C8-HSL) as well as 
smaller amounts of N-hexanoyl-homoserine lactone (C6-HSL). When the population density is 334 
sufficiently high, these AHLs will bind to CepR. This interaction will cause a conformational 
change in the latter regulatory protein and will result in the induction or repression of the 336 
transcription of the CepR target genes. Functions regulated by CepIR include the production of 
extracellular proteases (ZmpA and ZmpB), chitinases and the nematocidal protein AidA, swarming 338 
motility, biofilm maturation and ornibactin synthesis [90,96] (TABLE 1). In B. cepacia ATCC 
25416, CepR also influences the expression of RpoS, an alterative sigma factor that controls the 340 
gene expression in stationary phase cultures and in cultures exposed to certain environmental 
stresses [97]. A recent screening of a random promoter library in B. cenocepacia K56-2 identified 342 
89 genes to be regulated directly or indirectly by the CepIR QS system [98]. A comparison of the 
protein-expression pattern in a B. cenocepacia H111 wild type and H111 cepI mutant showed that 344 
5% of the proteome was downregulated in the mutant strain, whereas 1% was upregulated [99]. 
Using known CepR-regulated genes, a consensus cep box (i.e. CepR binding site)  motif was 346 
created and subsequently used to identify promotor regions that may be regulated by CepR [100] 
(FIGURE 1). Using this approach, 65 genes potentially regulated by CepR were identified, 348 
belonging to several functional classes : cell surface or membrane (9.2%), metabolism (33.9%), 
phages (3.1%), regulatory genes (21.5%), transport (4.6%), and secretion (4.6%). 12.3% of the cep 350 
boxes were located in promotor regions of genes encoding hypothetical proteins, 10.8% were 
located in genes encoding proteins of unknown function [100]. 352 
In addition to the transcription regulation of the above mentioned target genes, a positive feedback 
control of cepI by CepR, allowing a rapid AHL-signal amplification, has been described [101]. The 354 
discovery of three higher-level CepR regulators (YciR, SuhB and YciL) has added another layer of 
complexity to the already complex QS network [18]. In addition to the CepIR QS system, other QS 356 
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systems have been described within the B. cepacia complex. These include the CciIR, the CepR2 
and the BviIR QS systems [16]. The CciIR system is only present in epidemic B. cenocepacia 358 
strains containing the pathogenicity island called “cenocepacia island (cci)” and its function 
depends on the production of C6-HSL by CciI [98]. CepR2 is an orphan LuxR homolog in B. 360 
cenocepacia that influences the expression of several CepR and CciR regulated genes, but does not 
require an AHL for activation [96]. Besides the CepIR system, B. vietnamiensis strains are also 362 
equipped with a second QS system BviIR that relies on the production of N-decanoyl homoserine 
lactone (C10-HSL) [16]. An overview of the various systems in B. cenocepacia K56-2 and their 364 
interactions is shown in FIGURE 1. A selection of phenotypes and/or proteins regulated by the 
various systems in in B. cenocepacia K56-2 is shown in TABLE 1. 366 
 
Other QS systems in the B. cepacia complex 368 
Besides the AHL-based QS system, other QS systems employing 4-hydroxy-2-alkylquinolines 
(HAQ) [102] or cis-2-dodecenoic acid (“Burkholderia diffusible signal factor”, BDSF) [103] can be 370 
found in some B. cepacia complex strains.  
In P. aeruginosa, the Pseudomonas quinolone signal (PQS) is synthesised by enzymes encoded in 372 
the pqsABCDE operon : these enzymes generate 2-heptyl-4-quinolone (HHQ) from anthranilic acid, 
which is then converted to PQS by the FAD-dependent monoxygenase PqsH. PQS regulates the 374 
RhlI/R QS system but at the same time the las and rhl systems act antagonistically on pqsR,  the 
regulator of the pqsABCDE operon [102]. B. cenocepacia J415 was shown to produce HHQ, but not 376 
PQS [104]. In another member of the B. cepacia complex, B. ambifaria, a novel type of HAQs was 
identified, i.e. HAQs containg a methyl group and designated 4-hydroxy-3-methyl-2-378 
alkylquinolines (HMAQs) [105]. The genes involved in the biosynthesis of these HMAQs are 
located in the hmqABCDEFG operon ; mutations in hmqA or hmqG (encoding a putative 380 
methyltransferase) increase the production of AHLs in B. ambifaria, suggesting an important role 
for HMAQs in regulating QS-controlled phenotypes [105].  382 
BDSF is structurally similar to the diffusible signal factor in Xanthomonas campestris and its 
synthesis requires the presence of the X. campestris rpfF homologue [103]. This gene (BCAM0581 384 
in B. cenocepacia J2315) is also present in other sequenced B. cepacia complex genomes. 
Mutations in BCAM0581 are associated with growth defects, reduced virulence gene expression 386 
and attenuated virulence in a zebrafish infection model [106]. BDSF also inhibits germ tube 
formation in the human-pathogenic dimorphic fungus Candida albicans, potentially preventing 388 
infection with this fungus [103]. Interestingly, several AHL-regulated virulence genes in B. 
cenocepacia (including zmpA and orbI) are also under control of BDSF [106]. 390 
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QS and biofilm formation in the B. cepacia complex 392 
The link between QS and biofilm formation has extensively been studied in P. aeruginosa. Davies 
et al. [107] first showed that a functional QS system is required for the formation of differentiated 394 
biofilms with a marked threedimensional structure (“mushrooms”). In contrast, in other studies no 
[108] or only minor [109] differences were observed between a lasI deletion mutant and the wild 396 
type P. aeruginosa strain. However, QS inhibitors turned out to affect P. aeruginosa biofilm 
structure [110] and biofilms of mutants in which both the Las and the Rhl system were mutationally 398 
inactivated were more sensitive to tobramycin, hydrogen peroxide and leukocytes [111], suggesting 
a key role for QS in biofilm formation and resistance. Huber et al. [17] showed that QS also plays 400 
an important role in the development of B. cenocepacia H111 biofilms development. While 
biofilms formed by cep mutants are initially indistinguishable from biofilms formed by the wild 402 
type strain, the mutant biofilms did not develop further into mature biofilms. The QS – regulated 
genes required for this biofilm maturation have not been identified yet, but it has been speculated 404 
that FimA (the major subunit of type 1 fimbriae and produced under QS control) could be involved 
[16]. Futher analysis of a set of QS mutants of B. cenocepacia K56-2 [112] confirmed and extended 406 
the initial observations of Huber et al. [17]. cepI and cepR mutants formed biofilms with less 
biomass than the wild type biofilms, but neither the cciI nor the double cciI cepI mutant was 408 
deficient in biofilm formation. In the cciI mutant, C6- and C8-HSL are still being produced by the 
functional copy of cepI but for the double cciI cepI double mutant this phenotype is surprising, as 410 
very little biofilm formation would be expected in the absence of a functional AHL signal [112].  
The cciR mutant and the cepR cciIR mutant were both defective in biofilm formation. In the cciR 412 
mutant C6-HSL is still being produced by CepI and CciI, but this molecule  may be less efficient in 
binding to and/or activation of CepR than C8-HSL, resulting in (partial) inhibition of Cep-system 414 
regulated genes and biofilm formation [112]. In terms of susceptibility to antimicrobial agents, the 
individual cepIR and cciR mutants were not different from the wild type, but the cepI cciI mutant 416 
formed biofilms that were more sensitive to ciprofloxacin. Finally, biofilms formed by cciI and cepI 
mutants were more sensitive to removal by sodium dodecyl sulfate (TABLE 2). The observation 418 
that QS plays an important role in biofilm development in B. cenocepacia was subsequently 
extended to several other B. cepacia complex species [113] and it seems reasonable to assume that 420 
QS plays an important role in biofilm formation in all B. cepacia complex species. Nevertheless, it 
should be noted that results from one of the earliest studies investigating the link between QS and 422 
biofilm indicated that QS is likely not involved in regulating B. cepacia complex biofilm formation 
under all growth conditions [8]. 424 
In P. aeruginosa, PQS is also involved in biofilm formation, and addition of PQS enhances 
attachment of cells, possibly by inducing the production of the LecA lectin and/or the release of 426 
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extracellular DNA [102]. It is at present unclear whether HHQs, HMAQs and/or other molecules 
similar to HAQs are involved in biofilm formation in the B. cepacia complex. 428 
 
Inhibition of QS as a novel approach to treat B. cepacia complex biofilm-related infections 430 
Considering the major role of QS in B. cepacia complex biofilm formation, QS inhibitors have been 
proposed as potential novel antibiofilm agents [114,115]. In contrast to several QS systems in 432 
various other species, the AHL-based QS system of B. cenocepacia is not inhibited by furanone 
compounds [115]. Riedel et al. developed a set of QS blockers based on the structure of 3-oxo-C12-434 
HSL. These included N-(2-thienylcarbonyl)-4-bromo-1,5-dimethyl-1H-pyrazole-3-carbohydrazide 
(compound 1)  and N-(6-tert-butyl-2,3-dihydro-2-methylpyridazin-4-yl)-5-chlorothiophene-2-436 
carbohydrazide (compound 3) [116]. Besides drastically reducing the production of several 
virulence factors, compound 3 also turned out to be a potent inhibitor of biofilm formation in B. 438 
cenocepacia H111 (reduction of biofilm biomass with appr. 60%). Similar results were obtained for 
this compound when other B. cenocepacia and B. multivorans strains were tested [14]. In addition, 440 
compounds that were previously described as QS inhibitors also affected biofilm formation in B. 
cepacia complex bacteria [14]. More detailed investigation into the mode of action of several of 442 
these compounds revealed that at least some of them (including cinnamaldehyde and compound 3) 
promote detachment at later stages of the biofilm development, rather than interfering with the early 444 
phases of biofilm development. This is in agreement with the observations that QS mutants are not 
affected in early biofilm formation, but do show defects at later stages of the process [17]. 446 
 
 448 
Mixed species biofilms 
It has been shown that B. cepacia complex bacteria can form mixed species biofilms with P. 450 
aeruginosa, with sessile cells of both species being in close association [11,15,117]. In biofilms 
formed in various mixed-species biofilm model systems (including flow chambers and alginate 452 
beads in mouse lung tissue), both organisms produce AHL QS molecules, but interspecies 
signalling appeared to be unidirectional : while B. cenocepacia H111 reacts to signals produced by 454 
P. aeruginosa PAO1, the opposite is not the case [15]. It is likely that during chronic infections of 
the CF lung, both pathogens form mixed biofilms as well and as such the interactions between both 456 
bacteria merit further study. 
 458 
 
Conclusion 460 
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Biofilm formation and QS are important and wide-spread processes, that significantly impact the  
management and treatment of B. cepacia complex infections. Factors involved  in biofilm formation 462 
are the QS system(s), adhesive structures and various exopolysaccharides. When tested under 
comparable conditions, the MIC and MBIC, and the MBC and MBEC, respectively, were 464 
comparable for most antibiotics, although marked differences could be observed for tobramycine 
and various disinfectants. Various QS systems can be found in B. cepacia complex systems and it 466 
has been shown that the AHL-based system plays an important role in regulating biofilm formation. 
 468 
 
Future perspectives 470 
Although considerable progress has been made, a more comprehensive evaluation of the genes 
involved in biofilm formation is required in order to get a better understanding of the entire process. 472 
Besides identifying which genes are involved, a better insight into the dynamics of their expression 
will shed light on the role of these different genes under various conditions. At the same time, more 474 
research is needed to obtain a clearer picture of what factors are involved in the resistance of sessile 
B. cepacia complex cells. This may ultimately lead to the development of novel drugs with 476 
increased activity against B. cepacia complex bacteria. As it was clearly shown that QS plays an 
important role in biofilm development, QS inhibitors (alone or in combination with conventional 478 
antimicrobial agents) may hold great promise to treat B. cepacia complex infections. 
 480 
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Figure 1. (A) Organisation of the different quorum sensing systems in B. cenocepacia K56-2. 
Based on data previously reported in [16,90]. Regular arrows indicate flow from DNA to protein to 958 
AHL molecule (and subsequently to AHL-receptor complex, designated with *). Bold arrows 
indicate positive regulation. Dashed lines indicate negative regulation. CepR*, CciR* and CepR2* 960 
regulate the expression of a wide range of target genes, see [90] and Table 1 for details. (B) 
Graphical representation of the cep box motif.   The relative sizes of the letters indicate their 962 
likelihood of occurring at a particular position. Based on sequences reported in [100] and created 
with MEME Suite (http://meme.sdsc.edu/).  964 
 
Table 1. Reciprocal regulation of gene expression B. cenocepacia K56-2 by CepIR, CciR and 966 
CepR2. 
      CepIR   CciR   CepR2 968 
Motility     +    - 
Zinc metalloproteases   +    +, -   - 970 
AidA (nematocidal protein)  +    -   - 
Type VI secretion   +    - 972 
Heat shock proteins   +    -   + 
Efflux pumps    +, -    +, -   +, - 974 
Flp type pilus    +    -   
FimA (fimbrial protein)  +    - 976 
Lectins     +    -   - 
Ferric ornibactin transport  -    + 978 
Data from [90]. 
 980 
Table 2. Phenotype of various B. cenocepacia K56-2 QS mutants. 
 982 
    Biofilm biomass  MBEC (µg/ml)  Sensitive to removal 
    compared to WT  of ciprofloxacin  by SDS (24 h) 984 
          
K56-2 (WT)  NA    512    No  986 
Mutation  in :  
cepI   Reduced   512    Yes 988 
cepR   Reduced   1024    Yes 
cciI   Not affected  1024    ND 990 
cciR   Reduced   512    ND 
cepI cciI  Not affected  64    ND 992 
cepR cciIR  Reduced   ND    ND 
Data are from [112]. MBEC, minimum biofilm eradicating concentration. WT, wild type. NA, not 994 
applicable. ND, not determined 
